FrontierLab
A research filter, not a predictor — not financial advice. Grades rank growth stocks on evidence-based quality signals from end-of-day data; they are not buy/sell calls or price forecasts. Always do your own research.

BillionToOne, Inc. BLLN

Promising (early)   broader-coverage candidate · BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their

On FrontierLab's discovery record since 2026-06-12 (10 weeks ago) — when this name first surfaced. (distinct from the snapshot date below)

Auto-graded broader coverage — sourced by an automated screen and graded on default bands, not the sector-calibrated bands the curated screener uses. A "Promising (early)" here is NOT the same bar as a curated grade; these are auto-screened candidates for your own research, shown as of their surface date (2026-07-23), not the curated Frontier signal.

Key quality signals

Revenue growth (YoY)98.5%
Gross margin70.4%
Gross profits / assets0.36
Rule of 40108.7
Net margin10.2%
Cash runway (months)
PEG
Price / sales16.8

Quality checklist

Fundamentals — snapshot as of 2026-07-23

StageEarly
Share issuance (YoY)18.6% · heavy issuance
Moat
TAM
P/E (trailing)278.2
EPS (trailing)$0.46
Burn multiple
Gross-margin trend (pts)13.1
Cash / assets0.77
Net debt / EBITDA-9.6
Statements as ofQ1 FY2026 · filed 2026-03-31

Momentum context — a snapshot from 2026-07-23, not current

Price at surface$129.24 (as of 2026-07-23)
52-week range$61.96 – $138.7
% off 52-wk high-6.8%
RSI (14)61
Relative volume0.8×

Risk flags

Heavy dilution (~19%/yr) — top-decile share issuers have historically underperformed.Hyper-expansion — assets up ~124% in a year; aggressive expanders have historically lagged.

← All broader-coverage names · Curated names → · Open the interactive screener →

Data as of 2026-07-23 (end-of-day). How grades are computed →